Paper324694
Relationship between blood level of atenolol and pharmacologic effect.
Amery A and 4 others. Clin Pharmacol Ther, 1977. Cited by 62 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Relationship between blood level of atenolol and pharmacologic effect. Papers, record 324694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/324694
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atenolol | Major topic |
| Hypertension | Major topic |
| Propanolamines | Major topic |
| Adult | |
| Biological Availability | |
| Blood Pressure | |
| Clinical Trials as Topic | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Female | |
| Glomerular Filtration Rate | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Physical Exertion | |
| Placebos |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,186,443 | A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing. | J Hypertens | 2026 | https://conductscience.org/library/papers/42186443 | PubMed |
| 34,112,223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 17,892,982 | Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. | Am Heart J | 2007 | https://conductscience.org/library/papers/17892982 | PubMed |
| 12,844,326 | Therapeutic drug monitoring of antiarrhythmic drugs. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12844326 | PubMed |
| 8,841,737 | The implications of noncompliance with antihypertensive medication. | Drugs | 1996 | https://conductscience.org/library/papers/8841737 | PubMed |
| 7,418,712 | Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7418712 | PubMed |
| 7,308,277 | Relative activities of atenolol and metoprolol on the cardiovascular system of man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308277 | PubMed |
| 7,176,462 | Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/7176462 | PubMed |
| 7,002,567 | Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7002567 | PubMed |
| 6,994,790 | Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6994790 | PubMed |
| 6,814,568 | Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6814568 | PubMed |
| 6,749,509 | Clinical pharmacokinetics of atenolol--a review. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/6749509 | PubMed |
| 6,212,672 | Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists. | J Physiol | 1982 | https://conductscience.org/library/papers/6212672 | PubMed |
| 6,124,268 | Comparison between atenolol and nadolol in essential hypertension at rest and on exercise. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124268 | PubMed |
| 4,007,041 | Comparison of atenolol 50 mg and 100 mg as initial treatment in uncomplicated mild to moderate hypertension. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4007041 | PubMed |
| 3,970,785 | Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment. | Br Heart J | 1985 | https://conductscience.org/library/papers/3970785 | PubMed |
| 3,919,793 | Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes. | Br J Pharmacol | 1985 | https://conductscience.org/library/papers/3919793 | PubMed |
| 658,112 | Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/658112 | PubMed |
| 590,303 | Pharmacokinetics of atenolol in patients with renal impairment. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/590303 | PubMed |
| 465,278 | Pharmacokinetics, pharmacology of atenolol and effect of renal disease. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/465278 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/324694
GET https://conductscience.org/api/papers/v1/324694/cited_by?page=2